Stock 7AL ALLIGATOR BIOSCIENCE AB
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Alligator Bioscience AB Deutsche Boerse AG

Equities

7AL

SE0000767188

Market Closed - Deutsche Boerse AG
Other stock markets
 08:22:04 2024-05-31 EDT 		5-day change 1st Jan Change
0.093 EUR +18.62% Intraday chart for Alligator Bioscience AB +19.54% +64.31%
05-23 Alligator Bioscience to Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO Annual Meeting CI
05-21 US FDA Grants Investigational New Drug Clearance for Alligator Bioscience's Late-stage Gastric Cancer Treatment Trial MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alligator Bioscience's Pancreatic Cancer Combo Shows Improved Objective Response Rate in Mid-stage Study
MT
Alligator Bioscience Announces Positive Interim Results from Mitazalimab Optimize-1 Phase 2 Trial in Pancreatic Cancer Exceeding 50% Objective Response Rate
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ATORX Stock
  4. 7AL Stock
  5. News Alligator Bioscience AB
  6. Analyst Reco.